Types of bacteria vary widely in tumors of people with early vs. late-onset colorectal cancer

by Georgetown University Medical CenterCredit: Pixabay/CC0 Public DomainResearchers at Georgetown University's Lombardi Comprehensive Cancer Center studied the microbiome of people with color

Updated on: January 30,2024

Types of bacteria vary widely in tumors of people with early vs. late-onset colorectal cancer

by Georgetown University Medical CenterCredit: Pixabay/CC0 Public DomainResearchers at Georgetown University's Lombardi Comprehensive Cancer Center studied the microbiome of people with color

Updated on:January 30,2024

Too often, women aren't told of sexual side effects of cancer treatments

by Cara MurezWhen a man has cancer in an area that affects sexual function, his doctor is likely to discuss it with him.But the same is not true for a woman who has cancer in a sex organ, according to

Updated on: January 02,2024

Too often, women aren't told of sexual side effects of cancer treatments

by Cara MurezWhen a man has cancer in an area that affects sexual function, his doctor is likely to discuss it with him.But the same is not true for a woman who has cancer in a sex organ, according to

Updated on:January 02,2024

New study indicates treatment patterns, not genetics, drive prostate cancer disparities

by Sylvester Comprehensive Cancer CenterOverview of study design and overall genomic landscape (A) Study overview. The study comprised 11 741 patients with prostate cancer who underwent CGP to assess

Updated on: January 12,2024

New study indicates treatment patterns, not genetics, drive prostate cancer disparities

by Sylvester Comprehensive Cancer CenterOverview of study design and overall genomic landscape (A) Study overview. The study comprised 11 741 patients with prostate cancer who underwent CGP to assess

Updated on:January 12,2024

Link between sphingolipids and complement signaling may be key to stopping cancer metastasis

by Caroline Wallace,Medical University of South CarolinaGraphical Abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111742MUSC Hollings Cancer Center researchers have i

Updated on: January 02,2024

Link between sphingolipids and complement signaling may be key to stopping cancer metastasis

by Caroline Wallace,Medical University of South CarolinaGraphical Abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111742MUSC Hollings Cancer Center researchers have i

Updated on:January 02,2024

New study suggests way to predict outcomes with high accuracy prior to surgery for pancreatic cancer patients

by National Comprehensive Cancer NetworkPancreatic cancer cells (blue) growing as a sphere encased in membranes (red). Credit: National Cancer InstituteNew research in the September 2022 issue of&nbsp

Updated on: January 13,2024

New study suggests way to predict outcomes with high accuracy prior to surgery for pancreatic cancer patients

by National Comprehensive Cancer NetworkPancreatic cancer cells (blue) growing as a sphere encased in membranes (red). Credit: National Cancer InstituteNew research in the September 2022 issue of&nbsp

Updated on:January 13,2024

Researchers find effective drug combinations for glioblastoma in mice

by The Spanish National Cancer Research CentreTelomeres (red) in mouse embryonic fibroblasts; DNA damage (green) caused by ERK inhibition. ERK is an enzyme in the RAS pathway whose inhibition lea

Updated on: June 04,2024

Researchers find effective drug combinations for glioblastoma in mice

by The Spanish National Cancer Research CentreTelomeres (red) in mouse embryonic fibroblasts; DNA damage (green) caused by ERK inhibition. ERK is an enzyme in the RAS pathway whose inhibition lea

Updated on:June 04,2024

Novel therapeutic strategy against melanoma: Combined targeting of hedgehog signaling and BRD4

by Impact Journals LLCCombined targeting of SMO and BRD4 as a potential therapeutic strategy against melanoma. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28441A new editorial paper

Updated on: January 11,2024

Novel therapeutic strategy against melanoma: Combined targeting of hedgehog signaling and BRD4

by Impact Journals LLCCombined targeting of SMO and BRD4 as a potential therapeutic strategy against melanoma. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28441A new editorial paper

Updated on:January 11,2024

Researchers solving treatment resistance in most common breast cancer

by University of Pittsburgh Schools of the Health SciencesMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainAt Magee-Womens Research Institute (MWRI

Updated on: March 01,2024

Researchers solving treatment resistance in most common breast cancer

by University of Pittsburgh Schools of the Health SciencesMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainAt Magee-Womens Research Institute (MWRI

Updated on:March 01,2024

Researchers present advance in re-treatment with CAR T therapy

by Perelman School of Medicine at the University of PennsylvaniaHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0Researchers

Updated on: February 23,2024

Researchers present advance in re-treatment with CAR T therapy

by Perelman School of Medicine at the University of PennsylvaniaHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0Researchers

Updated on:February 23,2024

Policies favoring high-volume hospitals may disadvantage rural cancer patients

by University of PittsburghCredit: Pixabay/CC0 Public DomainPatients with cancer who live in rural Pennsylvania counties appear to know that they may have better outcomes if they receive their ca

Updated on: February 03,2024

Policies favoring high-volume hospitals may disadvantage rural cancer patients

by University of PittsburghCredit: Pixabay/CC0 Public DomainPatients with cancer who live in rural Pennsylvania counties appear to know that they may have better outcomes if they receive their ca

Updated on:February 03,2024

Researchers develop novel gold-nanocluster-based tumor radiodynamic therapy

by Zhang Nannan,Chinese Academy of SciencesGold-nanocluster-based radiodynamic therapy. Credit: IGDBRadiotherapy (RT) is a primary method of tumor treatment. However, in clinical practice, radio

Updated on: February 01,2024

Researchers develop novel gold-nanocluster-based tumor radiodynamic therapy

by Zhang Nannan,Chinese Academy of SciencesGold-nanocluster-based radiodynamic therapy. Credit: IGDBRadiotherapy (RT) is a primary method of tumor treatment. However, in clinical practice, radio

Updated on:February 01,2024

New research reviews myeloid-derived suppressor cells in cancer, autoimmune diseases, and more

by Impact Journals LLCMDSCs generated by obesity migrate to lymphoid organ and TME. Credit: 2022 Shibata et al.A new review titled "Myeloid-derived suppressor cells: Cancer, autoimmune diseases,

Updated on: January 12,2024

New research reviews myeloid-derived suppressor cells in cancer, autoimmune diseases, and more

by Impact Journals LLCMDSCs generated by obesity migrate to lymphoid organ and TME. Credit: 2022 Shibata et al.A new review titled "Myeloid-derived suppressor cells: Cancer, autoimmune diseases,

Updated on:January 12,2024